Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pichler Martin |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Khanna, Y; Michenthaler, H; Bourgeois, BMR; Pichler, M; Prokesch, A; Madl, T
Interplay of p53 and mRNA export factor THOC4 in Condensates
Regulation and Compartmentalization
Proceedings of the 19th NMR Winter Retreat of Protein-RNA Interactions 2025. 2025; -19th NMR Winter Retreat of Protein-RNA Interactions 2025; JAN 12-16, 2025; Parpan, SWITZERLAND.
[Oral Communication]
Huemer, M; Graca, S; Bitsche, S; Hofmann, G; Armour, M; Pichler, M
Mapping the Clinical Practice of Traditional, Complementary and Integrative Medicine in Oncology in Western Countries: A Multinational Cross-sectional Survey
Abstracts for SAR/RCMI PolyU International Research Conference. 2024; -SAR / RCMI PolyU International Research Conference; MAY 23-25, 2024; Hong Kong, CHINA.
[Poster]
FullText
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
Disordered regions regulate the interaction between p53 and the mRNA export factor THOC4
NMR Winter Retreat of Protein-RNA Interactions 2024; JAN 21-25, 2024; Parpan, Switzerland. 2024.
[Oral Communication]
Khanna, Y; Bourgeois, BMR; Pichler, M; Madl, T
Interplay of p53 and mRNA export factor THOC4 in Condensates
Regulation and Compartmentalization
EMBL Symposium: Cellular mechanisms driven by phase separation; MAY 14 - 17, 2024; Heidelberg, GERMANY. 2024.
[Poster]
Nestler, T; Paffenholz, P; Ruf, C; Che, Y; Seidel, CA; Heinzelbecker, J; Schmelz, H; Matthies, C; Albers, P; Bokemeyer, C; Heidenreich, A; Pichler, M; Majewski, M
Treatment efficacy implications of incorrect utilization of tumor marker levels and risk group assignment according to the International Germ Cell Consensus Classification (IGCCCG).
J CLIN ONCOL. 2024; 42(4_SUPPL): 505-505.
Doi: 10.1200/JCO.2024.42.4_suppl.505
[Poster]
Web of Science
FullText
FullText_MUG
Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Balihodzic, A; Fernandez-Hernandez, FJ; Jäger, V; Vosberg, S; Tonietto, M; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Doctoral Day of Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2917
[Poster]
Web of Science
FullText
FullText_MUG
Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E
Paired analysis of blood plasma and urine reveals complementary information
in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Oral Communication]
Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch, D; Pichler, M
Gender differences in using complementary and alternative medicine in cancer patients: a cross-sectional study
Doctoral Day 2023; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch D; Pichler, M
Gender Differences in Using Complementary and Alternative Medicine in Cancer Patients: A Cross-sectional Study.
EAPC2023 Abstract Book. 2023; 37(1S):92-92.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Huemer, M; Pichler, M; Richtig, G
Is Palliative Care Research Biased towards Oncology? Trends in Literature from 2000 to 2021: A Bibliometric Big Data Analysis.
EAPC2023 Abstract Book.. 2023; 37(S1):198-198.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Jonas, K; Prinz, F; Ferracin, M; Krajina, K; Deutsch, A; Madl, T; Rinner, B; Slaby, O; Klec, C; Pichler, M
MiR-4646-5p acts as a tumor-suppressive factor in triple negative breast cancer by targeting the cholesterol transport protein GRAMD1B.
13th Scientific Retreat of the DK-MCD; SEP 25-27, 2023; Seggau, AUSTRIA. 2023.
[Oral Communication]
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
The disordered regions of p53 and the mRNA export factor THOC4 regulate the interactions between them
NMR Winter Retreat of Protein-RNA Interactions 2023; JAN 15-19, 2023; Parpan, Switzerland. 2023.
[Poster]
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
The interaction between p53 and the mRNA export factor THOC4 is regulated by their disordered regions
5th Symposium "Frontiers in Integrative Structural Biology and Biophysics"; DEC 18, 2023; Graz, AUSTRIA. 2023.
[Poster]
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
The interaction between p53 and the mRNA export factor THOC4 is regulated by their disordered regions
ISTA NMR Symposium; MAY 2-3, 2023; Klosterneuburg. 2023.
[Poster]
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
The interaction between p53 and the mRNA export factor THOC4 is regulated by their disordered regions
XIIIth International conference « NMR: a tool for biology »; MAY 15-17, 2023; Paris, FRANCE. 2023.
[Poster]
Khanna, Y; Bourgeois, B; Pichler, M; Madl, T
The disordered regions of p53 and the mRNA export factor THOC4 regulate the interactions between them
Doctoral Day 2023; FEB 9, 2023; Graz, Austria. 2023.
[Poster]
Massari, F; Pulido, EG; Bamias, A; Iacovelli, R; Cerrillo, JM; Procopio, G; Fiala, O; Myint, ZW; De Giorgi, UFF; Buchler, T; Santini, D; Büttner, T; Roviello, G; Pichler, M; de los Rios, MTB; Rizzo, A; Monteiro, FSM; Buti, S; Porta, CG; Santoni, M
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immunecombinations
ANN ONCOL. 2023; 34: S1021-S1021.
Doi: 10.1016/j.annonc.2023.09.1127
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E
Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA.
[Poster]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E.
It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY.
[Poster]
Neufeldt, D; Jonas, K; Rinner, B; Szkandera, J; Rank, A; Jahn, S; Liegl-Atzwanger, B; Trepel, M; Pichler, M
Long non-coding RNA PANTR1 is associated with poor prognosis in sarcoma
ONCOL RES TREAT. Abstracts. 2023; 46(S5):156-156.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 13-16, 2023; Hamburg, GERMANY.
[Oral Communication]
Web of Science
Niedersüss-Beke, D; Krauter, J; Shariat, S; Pichler, R; Barth, D; Pichler, M; Weibrecht, S; Marszalek, M; Stoiber, F; Mayerhofer, K
Real-world data registry on patients treated with enfortumab vedotin in metastaic urothelial cancer in Austria
ONCOL RES TREAT. Abstracts. 2023; 46(S5):323-323.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 13-16, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
Paffenholz, P; Landwehr, G; Seidel, C; Poch, A; Bokemeyer, C; Cathomas, R; Pongratanakul, P; Hiester, A; Albers, P; Pichler, M; Krege, S; Syring-Schmandke, ; Heinzelbecker, J; Nestler, T; Pfister, D; Heidenreich, A
Non-seminomatous testicular germ cell tumours with teratoma-free primaries exhibit a superior early relapse-free survival
EUR UROL. 2023; 83:
[Poster]
Web of Science
Paffenholz, P; Landwehr, G; Seidel, CA; Poch, A; Bokemeyer, C; Cathomas, R; Pongratanakul, P; Hiester, A; Albers, P; Pichler, M; Krege, S; Syring, I; Heinzelbecker, J; Nestler, T; Pfister, D; Heidenreich, A
Relapse-free and overall survival in patients with non-seminomatous testicular germ cell tumours with teratoma-free primaries.
J CLIN ONCOL. 2023; 41:
[Poster]
Web of Science
Smolle, MA; Helmberg, W; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Einfluss der perioperativen Erythrozytenkonzentrat-Gabe auf die Prognose von WeichteilsarkompatientInnen.
2. Österreichischer Kongress für Orthopädie & Traumatologie; MAY 4-6, 2023; Vienna, AUSTRIA. 2023.
[Oral Communication]
Smolle, MA; Herbsthofer, L; Prietl, B; El-Heliebi, A; Pichler, M; Tomberger, M; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J
Impact Of Tumour-Infiltrating Immune Cells On Oncological Outcome (Local Recurrence, Distant Metastasis, Overall Survival) In Soft Tissue Sarcoma Patients.
Online Abstract Book of the 24th EFORT Congress. 2023; -24th EFORT Congress; MAY 24-26, 2023; Vienna, AUSTRIA.
[Oral Communication]
Balihodzic, A; Prinz, F; Jonas, K; Barth, DA; Dengler, MA; Slaby, O; Jost, PJ; Klec, C; Pichler, M
A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2022; 15: 37-67.-OeGHO- & AHOP-Frühjahrstagung; APRIL 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Balihodzic, A; Prinz, F; Jonas, K; Barth, DA; Dengler, MA; Slaby, O; Jost, PJ; Klec, C; Pichler, M.
A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma
8. International Student Congress Graz; JUNE 16-18, 2022; Graz, AUSTRIA. 2022.
[Poster]
Barth, D; Stradner, M; Hutterer, H; Spiegelberg, J; Bauernhofer, T; Absenger, G; Jost, P; Pichler, M
Blood-based B-cell subtypes as predictors of treatment response during treatment with immune checkpoint inhibitors: a prospective longitudinal pan-cancer study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2022. 2022; -OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Hochmair, M; Schmidinger, M; Ay, L; Robinson, I; Absenger, G; Pichler, M; Nguyen, VA; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A
BiomeOne: multi-center Validation of a new microbiome-based Biomarker to predict Response to Cancer Immunotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):229-229.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
Huemer, M; Jahn-Kuch D; Hofmann, G; Andritsch, E; Farkas C; Schaupp, W; Masel EK; Jost JP; Pichler M
Trends of public interest in palliative care, euthanasia, and advanced health care directives in Austria, Germany, and Switzerland using big data from Google
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2022; 22(3):17-17.-OeGHO & AHOP Frühjahrstagung; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Huemer, M; Pansi, A; Jahn-Kuch, D; Hofmann, G; Terbuch, A; Sciri, E; Spiegelberg, JA; Lipp, R; Pichler, M
Patterns of use of complementary and alternative medicine in cancer patients: A cross-sectional study
8th International Student Congress; JUN 16-18, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Khanna Y, Bourgeois B, Pichler M, Madl T
Biophysical characterization of p53 regulation by the mRNA export factor-THOC4
Frontiers in Integrative Structural Biology and Biophysics; DEC 13, 2022; Graz, Austria. 2022.
[Poster]
Khanna Y, Bourgeois B, Pichler M, Madl T
Biophysical characterization of p53 regulation by the mRNA export factor-THOC4
Robert Konrat's 60th: From Dynamics to Disorder and Beyond; SEP 28-29, 2022; Vienna, AUSTRIA. 2022.
[Poster]
Klec, C; Knutsen, E; Pasculli, B; Krajina, K; Deutsch, A; Perander, M; Graier, WF; Parrella, P; Pichler, M
The RNA-binding protein ALYREF is promoting triple negative breast carcinogenesis through CPSF6-mediated selective regulation of the short NEAT1 isoform
OeGHO- & AHOP-Frühjahrstagung 2022. 2022; -ÖGHO Frühjahrtagung ; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Klec, C; Stotz, M; Vychytilova-Faltejskova, P; Slaby, O; Gerger, A; Pichler, M
ALYREF regulates glucose metabolism and tumorigenesis in colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2022. 2022; -ÖGHO Frühjahrstagung; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Krajina, K; Kapeller, A; Dengler, M; Jost, P; Pichler, M; Klec, C
The long non-coding RNA NORAD and its relevance on PARP inhibitor sensitivity in triple negative breast cancer
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Mischinger, J; Schoellnast, H; Zurl, H; Geyer, M; Fischereder, K; Scheipner, L; Jasarevic, S; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, G; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Hutterer, G; Zigeuner, R; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
Combining targeted and systematic transrectal ultrasound guided prostate biopsy to improve verifcation and reduce misclassifcation of prostate cancer
Die Urologie 2022, 61 (Suppl 3):S159.
. 2022; -74. Kongress der Deutschen Gesellschaft für Urologie e.V.; 21.-24.09.2022; CCH Congress Center Hamburg, Deutschland.
[Oral Communication]
Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, GA; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, G; Pichler, M; Riedl, JM; Schöpfer-Schwab, S; Strobl, J; Hutterer, G; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
MRT gezielte Fusionsbiopsie der Prostata vs. systematische transrektale ultraschallgezielte Biopsie vs. kombiniertes Biopsieverfahren zur Detektion und korrekten Klassifikation des Prostatakarzinoms: eine retrospektive Kohortenstudie
German Medical Science GMS Publishing House; 2022. Doc22urobay38. doi: 10.3205/22urobay38. 2022; -48. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 19.-21.05.2022; Inselhalle Lindau, Deutschland.
[Oral Communication]
Richtig, G; Kienzl, M; Rittchen, S; Roula, D; Eberel, J; Sarif, Z; Pichler, M; Hoefler, G; Heinemann, A
Cannabinoids reduce melanoma cell viability and do not interfere with commonly used targeted therapy in metastatic melanoma.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
Robinson, I; Hochmair, MJ; Jansen, C; Pacifico, C; Sladek, B; Knabl, A; Gasche, N; Absenger, G; Pichler, M; Valipour, A
Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
WIEN KLIN WOCHENSCHR. 2022; 134(19-20): 742-742.
[Poster]
Web of Science
Robinson, I; Schmidinger, M; Hochmair, MJ; Ay, L; Absenger, G; Pichler, M; Nguyen, VAF; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A
BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
ANN ONCOL. 2022; 33(7):S592-S592.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); SEP 09-13, 2022; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2022.07.149
[Poster]
Web of Science
FullText
FullText_MUG
Sauseng, S; Imamovic, A; Kornprat, P; Waha, JE; Schemmer, P; Mischinger, HJ; Pichler, M
Is the new R0 resection the crucial corner stone within interdisciplinary therapy regimes to reach a prolonged OAS for PDAC patients
European Journal of Surgical Oncology. 2022; 48(2):134-134.-Congress of the European Society of Oncological Surgery; Nov 7-10, 2021; Lissabon.
[Oral Communication]
FullText
Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J
Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Poster]
Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Prognostic Effect Of Allogeneic Red Blood Cell Transfusions In Soft Tissue Sarcoma Patients. A Retrospective Study.
Advanced Scientific Programme EFORT Congress. 2022; -EFORT Annual Congress; JUN 22-24, 2022; Lisbon, PORTUGAL.
[Oral Communication]
Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Einfluss der perioperativen Erythrozytenkonzentrat-Gabe auf die Prognose von Weichteilsarkom-patient*Innen. Eine retrospektive Studie.
Abstractband DKOU 2022. 2022; -Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 25-28, 2022; Berlin, GERMANY.
[Oral Communication]
Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer
Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
FullText
Huemer, M; Gollner, K; Schlager, M; Karner, V; Gombocz, C; Pichler, M
Sexuality in Palliative Care: Practical Up-to-Date Guidelines for Overcoming Multidimensional Barriers in Communication, Support and Patient-education Concerning Sexual Needs of Chronically Ill
Abstracts from the 17th World Congress of the EAPC 2021. 2021; 35(1):1-243.-17th World Congress of the EAPC; OCT 6-8, 2021; Vilvoorde, BELGIUM.
[Poster]
FullText
Jonas, K; Prinz, F; Ferracin, M; Klec, C; Pichler, M
MicroRNA miR-4646-5p is a Novel Tumor Suppressive Factor in Triple Negative Breast Cancer.
11th Scientific Retreat of the DK-MCD; SEP 27-29, 2021; Seggau, AUSTRIA. 2021.
[Oral Communication]
Jonas, K; Prinz, F; Klec, C; Pichler, M
Characterization of Novel MicroRNAs Potentially Involved in Breast Carcinogenesis and Tumor Cell Metabolism
Doctoral Day of the Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
Klec, C; Seles, M; Fosselteder, J; Hutterer, GC; Slaby, O; Pichler, M
The Long non-coding RNA POU3F3 (PANTR1) as new player in clear cell renal cell carcinoma
Frühjahrstagung der ÖGHO. 2021; -Frühjahrstagung der ÖGHO; APR 8-10, 2021; Wien.
[Poster]
Pichler, M
Micro-RNA, molekularpathologische Testung und innovative Diagnostik 16:10
bei Keimzelltumoren - ein Update / MicroRNAs, precision oncology and
innovative diagnostics in testicular germ cell tumor patients - an update
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 1-4, 2021; Berlin, Germany. 2021.
[Oral Communication]
Pichler, M
MicroRNAs, precision oncology and innovative diagnostics in testicular germ cell tumor patients - an update
ONCOL RES TREAT. 2021; 44: 17-17.
Web of Science
Prinz, F; Jonas, K; Klec, C; Balihodzic, A; Pichler, M
Double-stranded RNA triggers cancer cells’ innate immune responses and leads to the upregulation of immunosuppressive immune checkpoint molecules.
11th Scientific Retreat of the DK-MCD; SEP 27-29, 2021; Seggau, AUSTRIA. 2021.
[Oral Communication]
Prinz, F; Jonas, K; Klec, C; Balihodzic, A; Pichler, M
Double-stranded RNA triggers cancer cells’ innate immune responses and leads to the upregulation of immunosuppressive immune checkpoint molecules.
11th Scientific Retreat of the DK-MCD; SEP 27-29, 2021; Seggau, AUSTRIA. 2021.
[Poster]
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
miRNA mimics can artificially influence the expression of immune checkpoint molecules in biliary tract cancer.
Doctoral Day - Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Seles, M; Foßelteder, J; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M
Oncogenic functions of long non-coding RNA PANTR1 in clear-cell renal cell cancer
Doctoral Day 2021@Medical University of Graz; FEB 12,2021; Graz. 2021.
[Onlinepräsentation]
FullText
Seles, M; Smolle, MA; Molnar, A; Riedl, JM;, Barth, DA; Terbuch, A, Rossmann, C; Mannweiler, S; Hutterer, GC, Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, MA; gerger, A, Pichler, M; Posch, F.
Metastasektomie bei metachron metastasierten Nierenzellkarzinompatient*innen - Wer, wann & wie?
73. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEp 15-18, 2021; Stuttgart, Germany. 2021.
[Oral Communication]
Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; Lopez-Garcia, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J
Einfluss von regulatorischen T-Zellen auf die Prognose von Weichteilsarkompatienten. Retrospektive, klinisch-pathologische Studie.
Abstract-Book der Sarkomkonferenz 2021. 2021; -Sarkomkonferenz; NOV 18-20, 2021; Berlin, GERMANY.
[Oral Communication]
Barth, DA; Brenner, C; Riedl, JM;Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M;Gerger, A; Pichler, M
External validation of the prognostic relevance of the Advanced Lung Cancer Infammation Index (ALI) in pancreatic cancer patients
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2020. 2020; 13 (Suppl 2): 23-65.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 19-21, 2020; Vienna, AUSTRIA.
[Poster]
Bauernhofer, T; Stanzer, S; Prietl, B; Kofler, S; Obermayer-Pietsch, B; Pichler, M; Sourij, H; Pieber, T
Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.
ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128.
[Poster]
Web of Science
Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A
Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167.
[Onlinepräsentation]
Web of Science
Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Jonas, K; Pichler, M
Characterization of Novel Non-Coding RNAs Potentially Involved in Breast Cancer Stem Cell Formation and Metabolism.
9th Scientific Retreat of the DK-MCD. 2020; -9th Scientific Retreat of the DK-MCD; JAN 20-21, 2020; Seggau, AUSTRIA.
[Oral Communication]
Jonas, K; Prinz, F; Klec, C; Pichler, M
Characterization of Novel Non-Coding RNAs Potentially Involved in Breast Carcinogenesis and Tumor Cell Metabolism.
10th Scientific Retreat of the DK-MCD. 2020; -10th Scientific Retreat of the DK-MCD; SEP 28-29, 2020; Graz, AUSTRIA.
[Oral Communication]
Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M
Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS19-P1-05-13
[Poster]
Web of Science
FullText
FullText_MUG
Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M
Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.202
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Laprovitera, N; Porcellini, E; Riefolo, M; Broseghini, E; Garajova, I; Sabbioni, S; Pichler, M; Ardizzoni, A; D'Errico, A; Ferracin, M
Cancer of unknown primary site-of-origin: An enigma ready to be miR-solved
CANCER RES. Abstracts. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; Virtuell.
Doi: 10.1158/1538-7445.AM2020-5432
[Poster]
Web of Science
FullText
FullText_MUG
Pichler, M
Role of Non-Coding RNA in colorectal cancer.
DK Nanocell Colloquium /Biophysics Colloquium (Invited Talk); JAN 14, 2020; Linz, Austria. 2020.
[Oral Communication]
Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM
C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.234
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
The influence of EMT-regulating microRNAs on immune checkpoint molecules.
9th Scientific Retreat of the DK-MCD; JAN 20-21, 2020; Seggau, AUSTRIA. 2020.
[Oral Communication]
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
Artificial miRNA mimics can distort physiological miRNA effects on immune checkpoint molecule expression by triggering an unspecific interferon response.
10th Scientific Retreat of the DK-MCD; SEP 28-29, 2020; Graz, AUSTRIA. 2020.
[Oral Communication]
Prinz, F; Reicher, A; Klec, C; Jonas, K; Posch, F; Pichler, M
The influence of EMT-regulating microRNAs on immune checkpoint molecules.
9th Scientific Retreat of the DK-MCD; JAN 20-21, 2020; Seggau, AUSTRIA. 2020.
[Poster]
Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215.
[Poster]
Web of Science
Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2013
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J
Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214.
[Poster]
Web of Science
Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM
Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2035
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Seles, M; Hutterer, GC; Foßelteder, J; Bauernhofer, T; Zigeuner, R; Pummer, K; Slaby, O; Pichler, M; Klec, C
Aufschlüsselung der onkogenen Funktionen der langen nicht-kodierende RNA "PANTR1" beim klarzelligen Nierenzellkarzinom.
72. Jahrestagung der Deutschen Gesellschaft für Urologie; Sept 23-26; Leipzig, Online. 2020.
[Onlinepräsentation]
Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M
Aufschlüsselung der onkogenen Funktionen der langen nicht-kodierende RNA "PANTR1" beim klarzelligen Nierenzellkarzinom.
72. Kongress der Deutschen Gesellschaft für Urologie; Sep, 14-26 2020; Hamburg, Germany/Virtuell. 2020.
[Onlinepräsentation]
Seles, M; Maisel, F; Smolle, M, Molnar, S; Riedl, JM; Barth, D; Terbuch, A; Rossman, CH; Mannweiler, S; Hutterer, GC; Zigeuner, RE; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Stöger, H; Pichler, M; Posch, F
Hilfestellung zur sinnvollen Indikation der Metastasektomie bei metachron metastasierten Nierenzellkarzinompatienten.
German Medical Science. 2020; -46. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; MAY, 14-16, 2020; Nuremberg, GERMANY..
[Onlinepräsentation]
FullText
Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477.
[Poster]
Web of Science
Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA.
[Poster]
Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108.
[Poster]
Web of Science
Feichtinger, J; Fechter, K; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic NR4A1 in Diffuse Large B Cell Lymphoma
5th International CCS Workshop and 15th International CLL Workshop Salzburg 2019; APR 5-6, 2019; Fuschl am See. 2019.
[Poster]
Feichtinger, J;
Fechter, K;
Prochazka, K;
Unterluggauer, JJ;
Pansy, K;
Steinbauer, E;
Pichler, M;
Haybaeck, J;
Prokesch, A;
Greinix, HT;
Beham-Schmid, C;
Neumeister, P;
Thallinger, GG;
Deutsch, AJA;
Cytoplasmic NR4A1 in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019.
[Poster]
Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293.
[Poster]
Web of Science
Huemer, M; Pichler, M; Jahn-Kuch, D
Implementing Complementary and Alternative Medicine into Standard Palliative Care: A Pilot Study.
9th International Seminar of the PRC, Pre-seminar for PhD's and post doctors - 23 October; OKT 23, 2019; Krems, AUSTRIA. 2019.
[Oral Communication]
Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoeger, H; Pichler, M
Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
San Antonio Breast Cancer Symposium. 2019; -SABCS; DEC 10-14; San Antonio, TX, USA.
[Poster]
Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M
Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Oral Communication]
Krstic, J; Reinisch, I; Depaoli, M; Berger, N; Noessing, C; Galhuber, M; Anders, I; Auer, M; Moyschewitz, E; Rinner, B; Pichler, M; Malli, R; Prokesch, A
Overcoming sorafenib resistance in hepatocellular carcinoma by fasting
BRIT J CANCER. 2019; 121: 16-17.
[Oral Communication]
Web of Science
FullText
Moser, T; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Speicher, MR; Heitzer, E
Molecular profiling of circulating tumor DNA in plasma of patients with renal cancer.
30th Annual Meeting of the German Society of Humangenetics ; MAR 6-8, 2019; Weimar, GERMANY. 2019.
[Poster]
Moser, T; Smith, CG; Mouliere, F; Chandrananda, D; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E
Untargeted profiling of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, ISRAEL. 2019.
[Poster]
Moser, T; Smith, CG; Mouliere, F; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E
Non-invasive tumor profiling via circulating tumor DNA in patients with renal tumors.
Doctoral Day 2019; NOV 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
FullText
Moser, T; Smith, CG; Seles, M; Pichler, M; Wcislo, G; Eldridge, M; Mouliere, F; Heider, K; Warren, A; Rosenfeld, N; D Stewart, GD; Heitzer, E
Comprehensive characterization of ctDNA in plasma and urine reveals renal cell carcinoma as a low ctDNA tumor type.
Advances in Circulating Tumor Cells (ACTC) 2019; SEP 2-6, 2019; Corfu, GREECE. 2019.
[Oral Communication]
FullText
Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg.
[Oral Communication]
FullText
Pondorfer, P; Molnar, S Kasparek, A.-K.; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Berger, A; Kapp, K.S;
Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D;
HPV infection as a predictive biomarker for response to induction chemotherapy and concomitant chemoradiation in patients with advanced head and neck squamous cell carcinoma
CEORL HNS; JUN 30, 2019; Brussels. 2019.
[Oral Communication]
FullText
Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE.
[Poster]
Web of Science
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
The influence of epithelial-mesenchymal transition on immune checkpoint molecules in biliary tract cancer
OEGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April 2019; Linz, AUSTRIA. 2019.
[Poster]
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA.
[Poster]
Reicher, A; Prinz, F; Klec, C; Stoeger, H; Moik, F; Posch, F; Pichler, M
Characterization of the fundamental role of fibroblast growth factor receptor 2 (FGFR2) gene fusions in carcinogenesis of intrahepatic cholangiocarcinoma using CRISPR/Cas9 genome engineering.
OEGHO- & AHOP-Frühjahrstagung 2019. 2019; -OeGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April, 2019; Linz, AUSTRIA.
[Poster]
Riedl, J; Stelzl, A; Aziz, F; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J
Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY .
[Poster]
FullText
Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A
Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115.
[Poster]
Web of Science
Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Riedl, JM; Stelzl, A; Aziz, F; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz,M; Gerger, A; Sourij, H; Szkandera, J
Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, Austria. 2019.
[Oral Communication]
Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; Stöger, H; Gerger, A; Riedl, JM
The AST/ALT ratio (de ritis) is an independent prognostic marker for disease free survival in stage II and III colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, AUSTRIA. 2019.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T.
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic renal cell carcinoma.
Europ Urolog Supplements. 2019; -Prize Winner Session at 34th Annual Congress of the European Association of Urology.; MAR 15-19; Bracelona, SPAIN.
[Oral Communication]
Seles, M; Foßelteder, J; Slaby, O; Klec, C; Mischinger, J; Hutterer, G; Pummer, K; Pichler, M
Identifikation und Charakterisierung einer neuen langen, nicht-kodierenden RNA RCA-lnc-RNA1 beim Nierenzellkarzinom
Der Urologe 2019, 58 (Suppl 1):S94/95.. 2019; -71. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 18-21, 2019; Hamburg Messe, Deutschland.
[Oral Communication]
Seles, M; Foseltseder, J; Mischinger, J; Klec, C; Slaby, O; Hutterer, GC; Pummer, K; Zigeuner, R; Pichler, M.
Identification and characterization of a novel long non-coding RNA RCA-lncRNA1 in clear cell renal cell carcinoma
European Urology Supplements
. 2019; 18(2):e2349--CEM19: 19th Central European Meeting in conjunction with the Austrian Association of Urology and the Bavarian Society of Urology ; 2019-05-10; Vienna, Austria.
[Oral Communication]
FullText
Seles, M; Foseltseder, J; Mischinger, J;Klec, C; Slaby, O; Hutterer, GC, Zigeuner, R; Pummer, K; Pichler, M P
Identifikation und Charakterisierung der neuen langen,nicht-kodierenden RNA RCA-lnc-RNA1
German Medical Science GMS Publishing House; 2019. Doc19oegu091 . 2019; -45. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY9-11 2019; Vienna, Austria.
[Oral Communication]
FullText
Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J
Advancing soft-tissue sarcoma aftercare using flexible parametric survival models.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY.
[Oral Communication]
Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J
Individualising soft tissue sarcoma aftercare with flexible parametric survival modelling.
Webabstracts of the 20th General Meeting of the International Society of Limb Salvage (ISOLS). 2019; -20th General Meeting of the International Society of Limb Salvage (ISOLS); SEP 11-14, 2019; Athens, GREECE.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Trenk, C; Prinz, F; Resel, M; Stoeger, H; Klec, C; Pichler, M
miR-4520s as potential regulator of breast carcinogenesis
Doctoral Day 2019. 2019; -Doctoral Day 2019, Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA.
[Poster]
Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
Fink-Neuböck, N; Lindenmann, J; Porubsky, C; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Anegg, U; Maier, A; Smolle-Jüttner, FM
How long should we follow up patients with stage I Non-Small Cell Lung Cancer after curative resection? An analysis of 300 cases using flexible parametric modelling of tumor recurrence and mortality rates.
Abstractband. 2018; -59. Österreichischer Chirurgenkongress; JUN 6-8, 2018; Vienna, Austria.
[Poster]
Hasenoehrl, C; Pichler, M; Sturm, E; Haybaeck, J; Schuligoi, R; Schicho, R
GPR55 promotes colorectal cancer through alterations of the tumor microenvironment
Joint DK-Retreat MCBO/MOLIN/IAI "Cancer, Inflammation, Immunity"; JAN 13-17, 2018; Obergurgl, AUSTRIA. 2018.
[Oral Communication]
Klec, C; Resel, M; Foßelteder, J; Prinz, F; Kapeller, A; Deutsch, A; Heitzer, E; Rinner, B; Stöger, H; Graier, WF; Pichler, M
Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1.
Retrain the Brain. Doctoral Day 2018. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Oral Communication]
Klocker, EV; Stotz, M; Posch, F; Stojakovic, T; Stoeger, H; Kornprat, P; Gerger, A; Pichler, M
A high AST/ALT (De Ritis)-Ratio represents a poor prognostic factor in a large cohort of patients with pancreatic cancer.
OeGHO Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
Koeller, M; Berger, M; Eder, S; Richtig, G; Richtig, E; Pichler, M; Winter, G; Hoefler, G; Aigelsreiter, A.
Is microsatellite-instability a prognostic factor in melanoma patients treated with immune-checkpoint inhibitors?
VIRCHOWS ARCH. 2018; 473: S9-S10.
[Oral Communication]
Web of Science
Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA
Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Poster]
Web of Science
Lindenmann, J; Fink-Neuböck, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Anegg, U; Maier, A; Smolle-Jüttner, FM
Prediction of clinical outcomes in stage I Non-Small Cell Lung Cancer after curative surgery focusing on the preoperative Glasgow Prognostic Score.
Abtsractband. 2018; -59. Österreichischer Chirurgenkongress; JUN 6-8, 2018; Vienna, AUSTRIA.
[Oral Communication]
Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F
Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248.
[Poster]
Web of Science
Pichler, M
Non-Coding RNA in colorectal cancer
Pharmazeutischen Kolloquiums
KARL - FRANZENS -UNIVERSITÄT GRAZ
INSTITUT FÜR PHARMAZEUTISCHE WISSENSCHAFTEN ; DEZ 13, 2018; Graz, Austria. 2018.
[Science to Public]
Pichler, M
APOBEC and FGFR Inhibitors in urothelial cancer
2. Translational Science Meeting; NOV 15-17, 2018; Innsbruck, Austria. 2018.
[Oral Communication]
Pichler, M
Immunonkologika bei Head and Neck Cancer
9te Wiener Head and Neck Tage; JAN 22-24, 2018; Vienna, Austria. 2018.
[Oral Communication]
Pichler, M.
Non-Coding RNAs in colorectal cancer metastases
; SEP 27, 2018; Brno, Czechia. 2018.
[Oral Communication]
Pichler, M;
Trends in Colorectal Cancer - Past, Present and Future
Invited Talk Department of Experimental Therapeutics, The UT MD Anderson Cancer Center (Prof. Calin); APR 5th, 2018; Houston, USA. 2018.
[Oral Communication]
Pichler, M;
Non-Coding RNAs in colorectal cancer metastases
Invited Talk Department of Cellular and Molecular Oncology, The UT MD Anderson Cancer Center (Prof. Tailer); APR 9th, 2018; Houson, USA. 2018.
[Oral Communication]
Pichler, M;
MicroRNAs and Long Non-Coding RNAs in colorectal cancer metastases
Invited Talk Department of Cancer Biology,, The UT MD Anderson Cancer Center (Prof. Schlacher); APR 9th, 2018; Houson, USA. 2018.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Pichler, M; Terzic, J; Mischinger, J; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Prädiktor bei TKI-Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
Der Urologe 2018, 57 (Suppl 1):S25/26.. 2018; -70. Kongress der Deutschen Gesellschaft für Urologie e.V.; 26.-29.09.2018; Messe Dresden, Deutschland.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic clear-cell renal cell carcinoma
Central European Meeting/European Association of Urology.; OCT 11-12,2018.; Cluj,ROMANIA.. 2018.
[Poster]
Seles, M; Fillhafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Vorhersageparameter bei targeted Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
German Medical Science GMS Publishing House;2018. Doc18urobay051. doi: 10.3205/18urobay051. 2018; -
44. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 14.-16.06.2018; Rosenheim, Deutschland.
[Oral Communication]
Smolle, MA; Riedl, JM; Stotz, M; Pichler, M; Kashofer, K; Gerger, A
Untersuchung von 22 Genen auf das progressionsfreie Überleben von Patienten mit metastasiertem Kolorektalen Karzinom.
OeGHO- & AHOP-Frühjahrstagung 2018 ; APR 19 - 21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Smolle, MA; van Praag, V; Posch, F; Bergovec; M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Jüttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Liegl-Atzwanger, B; Leithner, A
Effect of metastasectomy on overall-survival of patients with
metachronous metastasis of STS. A bi-centre study including
135 patients.
12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4-7, 2018; Jaipur, INDIA. 2018.
[Poster]
Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MAJ; Leithner, A
Metachronous metastasis of soft tissue sarcoma: Benefit of metastasectomy. A bi-centre study.
Abstractbook of the EMSOS 2018. 2018; -31st EMSOS Meeting; MAY 9-11, 2018; Amsterdam, THE NETHERLANDS.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
Unterluggauer, J; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J;
Molecular expression analysis reveals potential of translation initiation factors to serve as novel biomarkers for aggressive B-cell lymphomas.
Der Pathologe 39:67-68. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Rinner, B; Pichler, M; Weniger, M; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Specific translation initiation factors influence clinical course of aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Oral Communication]
Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR
Role of frequent chr13 q12.2 amplification in colorectal cancer patients
Role of frequent chr13 q12.2 amplification in colorectal cancer patients. 2018; -11th International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE.
[Poster]
Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silverstri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J..
Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
European Congress of Pathology; Sep 2.-6., 2017; Amsterdam. 2017.
[Poster]
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J
Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104.
[Poster]
Web of Science
Gantenbein,N; Bernhart,E; Anders,I; Golob-Schwarzl,N; Lindenmann,J; Fink-Neuböck,N; Brcic,L; Gollowitsch,F; Stacher-Priehse,E; Rolff,J; Hoffmann,J; Silvestri,A; Reinhard,C; Pehserl,AM; Pichler,M; Mitterer,V; Pertschy,P; Bergler,B; Popper,H; Sattler,W; Haybaeck,J
Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
CBmed Biomarker Conference; 13.2.2017; Graz, AUSTRIA. 2017.
[Poster]
Hasenoehrl, C; Sturm, E; Butcher, L; Pichler, M; Schuligoi, R; Haybaeck, J; Schicho, R
G protein-coupled receptor GPR55 promotes colorectal cancer.
27th Annual Symposium of the International Cannabinoid Research Society. 2017; -ICRS; JUN 22-27, 2017; Montreal, CANADA.
[Poster]
Leithner, A; Posch, F; Leitner, L; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Szkandera, J
Local Recurrence, Distant Metastasis, and Death in Patients with Soft Tissue Sarcoma after Curative Resection Using a Multi-state Model.
Abstractbook of 19th General Meeting of ISOLS. 2017; -ISOLS 2017; MAY 10-12, 2017; Kanazawa, JAPAN.
[Oral Communication]
Leitner, L; Posch, F; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Leithner, A; Szkandera, J;
Lokalrezidiv-Rate, Metastasierung und Mortalität nach Resektion lokalisierter Weichteilsarkome in kurativer Intention: Ein multi-state Model.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY.
[Oral Communication]
Lindenmann, J; Fink-Neuböck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Pichler, M; Bricic, L; Maier, A; Anegg, U; Smolle-Jüttner, FM
The Glasgow Prognostic Score as additional independent prognostic parameter for patients with malignant pleural mesothelioma.
European Surgery, Supplement 1
Abstracts 58th Annual Meeting of the Austrian Society of Surgery. 2017; 49(1):53-53.-58. Österreichischer Chirurgenkongress; JUN 28-30, 2017; Vienna, AUSTRIA.
[Oral Communication]
Lindenmann, J; Fink-Neubock, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Striessnig, A; Pichler, M; Brcic, L; Maier, A; Anegg, U; Smolle-Juttner, FM
The clinical impact of the Glasgow Prognostic Score as additional independent prognostic parameter for patients with malignant pleural mesothelioma
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):774-774.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA.
[Poster]
Web of Science
Lindenmann, J; Fink-Neubock, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Striessnig, A; Swatek, P; Pichler, M; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juttner, FM
How long should we follow up operated patients with stage I non-small cell lung cancer (NSCLC)?
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):772-772.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie- 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA.
[Poster]
Web of Science
Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM
PREDICTION OF CLINICAL OUTCOMES IN STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE SURGERY FOCUSING ON THE PREOPERATIVE GLASGOW PROGNOSTIC SCORE AND INFLAMMATORY BIOMARKERS.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 214-215.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM
HOW LONG SHOULD WE FOLLOW-UP PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE RESECTION? AN ANALYSIS OF 300 CASES USING FLEXIBLE PARAMETRIC MODELING OF TUMOR RECURRENCE AND MORTALITY RATES.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 166-167.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA.
[Poster]
FullText
Mayr, C; Wagner, A; Loffelberger, M; Bruckner, D; Jakab, M; Berr, F; Fazio, P; Ocker, M; Neureiters, D; Pichler, M; Kiesslich, T
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in binary tract cancer cells
ACTA PHYSIOL. 2017; 221: 250-252.
[Poster]
Web of Science
Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M
Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA.
[Oral Communication]
Partl R, Posch F, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J
Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse
Abstractband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik ; OCT 6-7; Linz, AUSTRIA.
[Poster]
Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T;
The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText
Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY.
[Oral Communication]
Richtig, G; Aigelsreiter, AM; Sygulla, S; Schauer, S; Asslaber, M; Pichler, M; Höfler, G; Aigelsreiter, A
Hedgehog pathway proteins SMO and GLI expression in head and neck squamous cell carcinoma – a potential therapeutic target?.
Virchows Arch. 2017; 471: S152-S152.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands.
[Poster]
Web of Science
FullText
Schneider, C; Wallner, M; Pichler, M; von Lewinski, D; Sedej, S; Rainer, PP
The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
European Heart Journal. 2017; 38(1):-ESC Congress; Aug 26-30, 2017; Barcelona, Spain.
[Poster]
Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Pichler, M, Hutterer, GC.
Kleine Thrombozyten im peripheren Blut repräsentieren einen prognostisch ungünstigen Faktor bezogen auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem Nierenzellkarzinom
German Medical Science GMS Publishing House.doi: 10.3205/17oegu021. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria.
[Oral Communication]
FullText
Seles, M; Stojakovic, B; Hager, B; Posch, F; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M; Hutterer GC.
Evaluierung des prognostischen Einflusses der präoperativen Zahl eosinophiler Granulozyten im peripheren Blut auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem klarzellligen Nierenzellkarzinom
German Medical Science GMS Publishing House; 2017. Doc17oegu022. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria.
[Oral Communication]
FullText
Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J;
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas.
29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, NETHERLANDS. 2017.
[Oral Communication]
Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas
VIRCHOWS ARCH. 2017; 471: S43-S43.
[Poster]
Web of Science
Unterluggauer, J; Beham-Scmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Comprehensive expression analysis indicates translation initiation factors as novel biomarkers for aggressive B-cell lymphomas.
Herbsttagung der ÖGPath/IAP Austria; SEP 14-16, 2017; Velden, AUSTRIA. 2017.
[Poster]
Unterluggauer, J; Seeboeck, R; Tomazic, PV; Huber, HJ; Fechter, K; Steinbauer, E; Rinner, B; Pichler, M; Weniger, M; Kueppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Comprehensive expression analysis indicates translation initiation factors as novel biomarkers for aggressive B-cell lymphomas
Doctoral Day 2017 Medical University of Graz; DEZ 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR
Investigation of the role of frequent chr13 q12.2 focal amplification in
colorectal cancer patients
17. Jahrestagung der Österreichischen Gesellschaft für Humangenetik (ÖGH); SEP 29, 2017; Graz, AUSTRIA . 2017.
[Oral Communication]
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016.
[Oral Communication]
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M;
23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY.
[Oral Communication]
FullText
Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1
Blood. 2016; -58th Anual Meeting of the American Society of Hematology; Dec 3-6, 2016; San Diego, CA, USA.
[Poster]
Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P;
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
Doi: 10.1182/blood.V128.22.2728.2728
Web of Science
FullText
FullText_MUG
Diana Bonilla, Kimberlyn Acklin, Kathryn Ruissard, Martin Pichler, Richard Jones, Anna Sergueeva, David
Dwyer, Ryan Jewell, Veena Papanna, Shobana Vaidyanathan, Karen Ramirez, Karen Clise-Dwyer
Development of a Multiplexing Imaging Flow
Cytometry Assay for Apoptosis Evaluation
Cyto conference 2016. 2016; -31st Conference of the International Society for Advancement of Cytometry; JUN 11-15, 2016; Seattle, USA.
[Poster]
Gilg, MM; Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Berghold, A; Ferstl-Rohrbacher, A; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J
Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Poster]
HUI LING1, Masahisa Ohtsuka1, Martin Pichler2, Cristina Ivan1, Daisuke Matsushita1, George Calin1
The functional involvement of H19, a Long noncoding RNA, in human colorectal cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA.
[Poster]
Martin Pichler1, Stefanie Cerk1, Verena Stiegelbauer1, Daniela Schwarzenbacher1, Hui Ling2
A novel long non-coding RNA, TSA-LINC2, regulates cellular growth and is associated with poor prognosis in breast cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA.
[Poster]
Mohammed H. Rashed1, Pinar Kanlikilicer1, Cristian Rodriguez Aguayo1, Nashwa N. Kabil1, Martin Pichler1, Recep Bayraktar1, Emine Bayraktar1, Cristina Ivan1, Rahul Mitra1, George A. Calin1, Anil K. Sood1, Mohamed F. Abd-Ellah2, Gouda K. Helal2, Gabriel Lopez Berestein1
Ovarian cancer cells selectively release exosomes containing tumor suppressor miRNAs to maintain SRC-mediated oncogenic activities
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA.
[Poster]
Pinar Kanlikilicer, Mohammed Mohammed H. S. Rashed, Recep Bayraktar, Rahul Mitra, Cristina Ivan, Burcu Aslan, Xinna Zhang, Rodriguez-Aguayo Cristian, Emine Bayraktar, Martin Picher, Bulent Ozpolat, George A. Calin, Anil K. Sood, Gabriel Lopez-Berestein.
Exosomal miR-6126 as a novel tumor suppressor in ovarian cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA.
[Poster]
Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL.
[Oral Communication]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J
Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL.
[Poster]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL.
[Poster]
Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J
Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016.
[Oral Communication]
Recep Bayraktar, Martin Pichler Pichler, Cristina Ivan, George Calin, Bulent Ozpolat
miR-603 acts as a tumor suppressor in triple-negative breast cancer and inhibits cell proliferation, invasiveness and tumorigenesis by targeting elongation factor 2-kinase (eEF2K)
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA.
[Poster]
Richtig, E; Richtig, G; Kashofer, K; Heinemann, A; Pichler, M; Höller, C; Aigelsreiter, A
RAS und RAF – together forever.
26. Deutschen Hautkrebs Kongress ; Sept 22-24, 2016; Dresden. 2016.
[Oral Communication]
Richtig, G; Aigelsreiter, AM; Lackner, C; Hoefler, G; Pichler, M; Aigelsreiter, A
SOX-9 expression is associated with better clinical outcome in patients with hepatocellular carcinoma
3rd Annual Joint Meeting of the Austrian and Swiss Societies of Pathology; NOV 10-12; Vienna, AUSTRIA. 2016.
[Poster]
FullText
Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw370.107
[Poster]
Web of Science
FullText
FullText_MUG
Schneider, C; Wallner, M; Abdellatif, M; von Lewinski, D; Pichler, M; Sedej, S; Rainer, P
The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
WIEN KLIN WOCHENSCHR. 2016; 128: S309-S310.
[Poster]
Web of Science
Seles, M; Strini, KA; Pohlmann, K; Bezan, A; Pummer, K; Pichler, M; Zigeuner, R; Hutterer, GC
Prognostische Bedeutung klinischer und histopathologischer Parameter hinsichtlich des Gesamtüberlebens beim Nierenzellkarzinom – Langzeitanalyse eines europäischen Single-Centers 1984-2013
GMS Ger Med Sci. 2016; doi: 10.3205/16urobay052, urn:nbn:de:0183-16urobay0523. 2016; -42. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; JUN 2-4, 2016; Augsburg, Germany.
[Oral Communication]
FullText
Seles, M;Hutterer, GC;Zigeuner, R; Pummer, K; Pichler, M.
Lange, nicht-kodierende RNA in Stammzellen des
Nierenzellkarzinoms.
Jahrestagung der Österreichischen Gesellschaft für Urologie und Andrologie.; NOV, 3-4, 2016; LINZ. 2016.
[Oral Communication]
Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A
LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion.
European Respiratory Journal 2016 48: PA3399. 2016; 48: -ERS International Congress ; SEP 3-7, 2016; London, UNITED KINGDOM.
[Poster]
FullText
Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A
Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773.
[Poster]
Web of Science
Smolle, MA; Pichler, M; Flick, H; Olschewski, H; Lindenmann, J; Samonigg, H; Gerger, A.
Einfluss von nicht-steroidalen Antirheumatica (NSARs) sowie Laborparametern auf den Erfolg einer chemischen Pleurodese bei malignen Pleuraergüssen.
European Surgery, Supplement 1
Abstracts 57th Annual Meeting of the Austrian Society of Surgery. 2016; 48(1):46-46.-57. Österreichischer Chirurgenkongress; MAY 25- 27, 2016; Salzburg, AUSTRIA.
[Oral Communication]
Smolle, MA; Pichler, M; Roßmann, C; Samonigg, H; Heitzer, E; Belic, J; Speicher, M; Pummer, K; Bauernhofer, T
Neuroendocrine transdifferentiation in castration resistant metastatic prostate cancer (mCRPC) - A case series
OeGHO & AHOP Frühjahrstagung; MAR 17 - 19, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Stiegelbauer, V; Schwarzenbacher, D; Pehserl, A, Adiprasito, JB, Deutsch, A; Stöger, H; Haybaeck, J; Stotz, M; Höfler, G; Gerger, A; Pichler, M
MicroRNA196 regulates metastases formation in colorectal cancer
8th ÖGMBT Annual Meeting; SEP 12-14, 2016; Graz. 2016.
[Oral Communication]
Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A
Local recurrence, distant metastasis, and death in patients with soft tissue
sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Oral Communication]
Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A
Conditional survival of patients with soft tissue sarcoma (STS) after curative
Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Oral Communication]
Thomas Winder, Michael Stotz, Alexander Rheinhard Siebenhuener, Konstantin Schlick, Teresa Magnes, Panagiotis Samaras, Joanna Szkandera, Pierre-Alain Clavien, Daniel Neureiter, Richard Greil, Bernhard C. Pestalozzi, Armin Gerger, Alexander Egle, Martin Pichler
The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients
ASCO 2016. 2016; -ASCO; JUN 3-7, 2016; Chicago, USA.
[Poster]
Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
16. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M
An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw371.77
[Poster]
Web of Science
FullText
FullText_MUG
Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T
IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.455
[Poster]
Web of Science
FullText
FullText_MUG
Zhou, Q; Perakis, S; Ulz, P; Heitzer, E; Pichler,M; Gerger, A; Bauernhofer, T; Geigl, JB; Speicher, MR
Monitoring targeted therapy response by cell-free circulating tumor DNA in metastatic colorectal cancer
Doctoral day; DEC 14, 2016; Graz, Austria. 2016.
[Poster]
Bezan, A; Hutterer, GC; Golbeck, S; Mrsic, E; Krieger, D; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents) - a European single-center experience over 26 years
ÖGHO 2015; APRIL 23-25, 2015; Salzburg. 2015.
[Poster]
Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M
The pre-operative AST/ALT (DeRitis) ratio represents a poor prognostic factor in a cohort of non-metastatic renal cell carcinoma patients
J Urol. 2015 Jan 23. 2015; -ÖGHO 2015; April 23-25, 2015; Salzburg.
[Poster]
Gary, T; Pichler, M; Rief, P; Hafner, F; Brodmann, M
The AST/ALT Ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease Patients
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):721-721.
[Poster]
Web of Science
Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nußbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
Oncology Research and Treatment. 2015; 38: -Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OKT 9-13, 2015; Basel, SWITZERLAND. (ISBN: 978-3-318-02811-9 )
[Oral Communication]
Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99.
[Oral Communication]
Web of Science
Hutterer, GC; Dalpiaz, O; Ehrlich, GC; Mrsic, E; Krieger, D; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M
Validierung der präoperativen Thrombozyten-Lymphozyten-Ratio (PLR) als Prognosefaktor beim Urothelkarzinom des oberen Harntraktes in einer europäischen Single-Center-Serie
Der Urologe 2015;(54)Suppl 1: 126. 2015; -67. Kongress der Deutschen Gesellschaft für Urologie e.V.,; SEP 23-26, 2015; Congress Center Hamburg, Hamburg, Germany.
[Oral Communication]
Hutterer, GC; Golbeck, S; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents) - a European single-center experience over 26 years
J Urol Suppl 2015;193(4):e867. 2015; -American Urological Association (AUA) Annual Meeting; May 15-19, 2015; New Orleans, LA, USA.
[Poster]
Hutterer, GC; Golbeck, S; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents) - a European single center experience over 26 years
Eur Urol Suppl 2015;14/2;e2. 2015; -30th Annual EAU (European Association of Urology) Congress; 20-24 MAR; Madrid, SPAIN.
[Poster]
Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL.
Doi: 10.1200/jco.2015.33.7_suppl.513
[Poster]
Web of Science
FullText
FullText_MUG
Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
Doi: 10.1200/jco.2015.33.15_suppl.e15617
[Poster]
Web of Science
FullText
FullText_MUG
Jesche-Chromecki, J; Hutterer, GC; Dalpiaz, O; Mrsic, E; Krieger, D; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M
Validierung der präoperativen Thrombozyten-Lymphozyten-Ratio (PLR) als Prognosefaktor beim Urothelkarzinom des oberen Harntraktes in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House;2015. DOI:10.3205/15oegu51. 2015; -41. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 11.-13.06.2015; Linz, AUSTRIA.
[Oral Communication]
Krenn-Pilko, S; Langsenlehner, U; Thurner, E; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer.
BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0960-9776(15)70261-4
[Poster]
Web of Science
FullText
FullText_MUG
Krieger, D; Mrsic, E; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC
Die prognostische Relevanz von Leukozytose, Thrombozytose und Anämie bei PatientInnen mit nicht-metastasiertem Nierenzellkarzinom
German Medical Science GMS Publishing House;2015. DOI:10.3205/15oegu26. 2015; -41. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 11.-13.06.2015; Linz, AUSTRIA.
[Oral Communication]
Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
ACTA PHYSIOL. 2015; 213: 148-148.
[Poster]
Web of Science
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
ACTA PHYSIOL. 2015; 213: 147-148.
[Poster]
Web of Science
Nußbaumer, E; Hatzl, S; Kuepper, K; Geiger, O; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Lavrencic, M; Woelfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of RAF kinase inhibitor protein in acute myeloid leukemia is caused by the overexpression of miRNA-15a.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, VIENNA.
[Poster]
Ress, Anna Lena; Stiegelbauer, Verena; Schwarzenbacher, Daniela; Deutsch, Alexander; Ling,Hui; Calin, George; Rinner, Beate; Gerger, Armin; Samonigg, Hellmut; Pichler, Martin.
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
. 2015; -Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25.04; Salzburg.
[Poster]
Rief, P; Pichler, M; Hafner, F; Gerger, A; Eller, P; Hackl, G; Brodmann, M; Gary, T
De Ritis Score und CLI
Z f Gefäßmedizin. 2015; -Sailersymposium; Jun 18-19, 2015; Graz.
[Poster]
S. Krenn-Pilko, U. Langsenlehner, E.-M. Thurner, T. Stojakovic, M. Pichler, A. Gerger, K.S. Kapp, T. Langsenlehner
An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer
Poster and Abstract search Forum. 2015; -2015 St. Gallen Breast Cancer Conference; MAR 18-21, 2015; Vienna.
[Poster]
FullText
S. Krenn-Pilko, U. Langsenlehner, E.M. Thurner, T. Stojakovic, M. Pichler, A. Gerger, K.S. Kapp, T. Langsenlehner
External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients
Radiotherapy and Oncology, Journal of the European Society for Radiotherapy and Oncology. 2015; 115(1):356-356.-3rd ESTRO Forum Barcelona; APR 24-28, 2015; Barcelona.
[Poster]
FullText
Stotz, M; Herzog, SA; Pichler, M; Szkandera, J; Schaberl-Moser, R; Samonigg, H; Renner, W; Berghold, A; Gerger, A;
Cancer stem cell gene variants and colon cancer prognosis.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25, 2015; Salzburg. 2015.
[Poster]
Strini, KA; Hutterer, G; Golbeck, S; Mrsic, E; Krieger, D; Bezan, A; Jesche-Chromecki, J; Pummer, K; Pichler, M; Zigeuner, R
Vergleich der Überlebenszeiten von PatientInnen mit metastasiertem Nierenzellkarzinom anhand zweier historischer Vergleichskohorten (Zytokintherapie vs. Targeted Agents) – eine europäische Single-Center Serie über 26 Jahre
German Medical Science GMS Publishing House;2015. DOI:10.3205/15oegu23. 2015; -41. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 11.-13.06.2015; Linz, AUSTRIA.
[Oral Communication]
Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
Ulz, P; Heitzer, E; Belic, J; Lafer, I; Schwarzbraun, T; Bauernhofer, T; Eisner, F; Pichler, M; Fischereder, K; Gutschi, S; Augustin H; Pummer K; Webersinke, G; Geigl, JB; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
15. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 25, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
V. Stiegelbauer,
A. Ress,
D. Schwarzenbacher,
A. Deutsch,
S. Perakis,
H. Ling,
C. Ivan,
G. Calin,
A. Gerger,
B. Rinner and
M. Pichler
The role of the putative tumor suppressor protein spinophilin in colorectal cancer
Ann Oncol (2015) 26 (suppl 4): iv64 doi:10.1093/annonc/mdv233.216 . 2015; -ESMO World Congress on Gastrointestinal Cancer; JUL 1-4, 2015; Barcelona, Spain.
[Poster]
Woitas, R; Scharnagl, H; Kleber, ME; Grammer, TB; Pichler, M; März, W; Stojakovic, T
Impact of neutrophil gelatinase-associated lipocalin and neutrophil counts in the Ludwigshafen Risk and Cardiovascular Health Study.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015.
[Oral Communication]
Bezan, A; Hutterer, G; Stöckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M;
Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma partients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Bezan, A; Hutterer, G; Stöckigt, C; Stojakovic, T; Samonigg, H; Pummer, K; Zigeuner, R; Pichler, M;
High pre-operative monocyte-lymphocyte ratio (MLR) as a prognostic factor in non-metastatic clear cell renal cell carcinoma
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Bezan, A; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M;
A large scale validation study proposes high pre-operative plasma fibrinogen levels as an independent negative prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma patients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Brookman-May, S; Cindolo, L; Zigeuner, R; Pichler, M; Sountoulides, P; Stief, C; Waidelich, R; Dalpiaz, O; Gilfrich, C; May, M; Schips, L
Nierenzellkarzinom-Patienten <80 Jahren haben eine signifikant höhere krebsspezifische und nicht-krebsspezifische Mortalität nach operativer Therapie-Ergebnisse einer komparativen Analyse von Patienten <80 Jahren und Patienten in der 7. Lebensdekade unter Integration von Competing-Risks-Analysen
J Urol Urogynäkol. 2014; 21(4):10-10.-40. Gemeinsame Tagung der Bayerischen Urolgenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; MAY 15-17, 2014; Erlangen, GERMANY.
[Oral Communication]
Brookman-May, SD; Ficarra, V; Shariat, S; Zigeuner, R; Chromecki, T; Cindolo, L; Gunia, S; Aziz, A; Otto, W; Pahernik, S; Chun, F; Becker, A; Simeone, C; Longo, N; Zucchi, A; Stabiano, S; D'Alterio, C; Gilfrich, C; Schips, L; De Cobelli, O; Joniau, S; Waidelich, R; Pichler, M; Rocco, B; Tubaro, A; Feciche, B; Truss, M; Dalpiaz, O; Zastrow, S; Wirth, M; Santiago Martin, M; Hoschke, B; Stief, C; May, M
Prognostic influence of chromophobe subtype and sarcomatoid dedifferentiation in patients with renal cell carcinoma and impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma (CDRCC): Results of comprehensive analyses of the CORONA and SATURN databases and development of a disease-specific risk-model for CDRCC patients
Eur Urol Suppl 2014. 2014; 13(1):e317-e317.-29th Annual EAU Congress; APR 11-15, 2014; Stockholm, SWEDEN.
[Poster]
Brookman-May, SD; Zigeuner, R; Sountoulides, P; Truss, M; Dalpiaz, O; Wolff, I; Hoschke, B; Gilfrich, C; Pichler, M; Waidelich, R; Stief, C; Cindolo, L; Schips, L; May, M
Nierenzellkarzinom-Patienten ≥80 Jahren haben eine signifikant höhere krebsspezifische und nicht-krebsspezifische Mortalität nach operativer Therapie als Patienten im typischen Erstdiagnosealter zwischen 60 und 70 Jahren – Ergebnisse einer komparativen Analyse dieser Altersgruppen unter Integration von Competing-Risks-Analysen
Der Urologe Suppl. 2014; 53(1):114-114.-66. Kongress der Deutschen Gesellschaft für Urologie e.V.; OCT 1-4, 2014; Düsseldorf, GERMANY.
[Oral Communication]
Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M
Elevated blood urea nitrogen is associated with CLI in PAOD patients
EUR HEART J. 2014; 35: 631-631.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
Web of Science
Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M
BUN und CLI
DGA; Hamburg. 2014.
[Poster]
Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M
BUN und CLI
DGA; Hamburg. 2014.
[Oral Communication]
Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich H; Eller, P; Pilger, E; Brodmann, M
NLR und PLR und der Zusammenhang mit der kritischen Extremitätenischämie
DGA ; Hamburg. 2014.
[Keynote lecture]
Hutterer, GC; Dalpiaz, O; Sobolev, N; Martín Hernández, JM; Stojakovic, T; Eberhard, K; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M
Validierung der präoperativen Lymphozyten-Monozyten-Ratio (LMR) als Prognosefaktor beim Urothelkarzinom des oberen Harntraktes in einer europäischen Single-Center-Serie
Der Urologe 2014;(53)Suppl 1: 81.. 2014; -
66. Kongress der Deutschen Gesellschaft für Urologie e.V.; OCT 1-4, 2014; Düsseldorf, Germany.
[Oral Communication]
Hutterer, GC; Stöckigt, C; Stojakovic, T; Martín Hernández, JM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M
High pre-operative monocyte-lymphocyte ratio (MLR) represents a poor prognostic factor in non-metastatic clear cell renal cell carcinoma
Eur Urol Suppl 2014;13;e320. 2014; -29th Annual EAU (European Association of Urology) Congress
; APR 11-15; Stockholm, SE.
[Poster]
Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R
High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4):
Doi: 10.1200/jco.2014.32.4_suppl.534
[Poster]
Web of Science
FullText
FullText_MUG
Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients
EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
[Poster]
Web of Science
Krenn-Pilko S., Langsenlehner U., Thurner E.-M., Stojakovic T., Pichler M., Gerger A., Kapp K.S., Langsenlehner T.
Der präoperativ erhöhte Plasma-Fibrinogen-Spiegel ist als prädiktiver Faktor für die Prognose von Brustkrebs Patientinnen
Abstractband ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik. 2014; -ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik; OKT 3-4, 2014; Innsbruck, AUSTRIA.
[Poster]
Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T;
The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA.
[Poster]
Web of Science
Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T;
Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA.
[Poster]
Web of Science
Kuepper, MK; Wolf, O; Huber-Krassnitzer, B; Wieser, R; Pichler, M; Scheideler, M; Woelfler, A; Sill, H; Zebisch, A
Overexpression of miR-23a, miR-24 and miR-15a in acute myeloid leukemia with loss of the RAF kinase inhibitor protein.
memo-magazine of european medical oncology 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Oral Communication]
Rief, P; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Eller, P; Brodmann, M; Gary, T
Elevated Blood Urea Nitrogen is Associated with CLI in PAOD Patients
Zeitschrift für Gefäßmedizin. 2014; -Sailersymposium; Jun 12-13, 2014; Graz.
[Poster]
Stotz, M; Pichler, M; Bezan, A; Peinsith, H; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A
The preoperative C-reactive protein (CRP) and fibrinogen level predicts clinical outcome in patients with stage III colon cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Jahrestagung der DGHO, ÖGHO, SGMO und SGH ; OKT 10-14, 2014; Hamburg, Deutschland. 2014.
[Oral Communication]
Thurner, EM; Krenn-Pilko, S; Gerger, A; Pichler, M; Kapp, KS; Langsenlehner, U; Langsenlehner, T
The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients
ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY.
[Oral Communication]
Web of Science
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, K; Langsenlehner, T
C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients
STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY.
[Poster]
Web of Science
Thurner, EM; Krenn-Pilko, S; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T
Elevated C-reactive protein level predicts poor prognosis in prostate cancer patients treated with radiotherapy.
Journal of the European Society for Radiotherapy and Oncology.. 2014; 111(Supp 1):129-129.-ESTRO 33; APR 4-8, 2014; Vienna, AUSTRIA.
[Oral Communication]
Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
Troppan K; Wenzl K; Deutsch A; Schwarzenbacher D; Pichler M; Graupp M; Neumeister P
Hohe Expression von microRNA-199a_1 und microRNA-497_1 ist assoziiert mit besserem Überleben bei patienten mit aggressivem non-Hodgkin-Lymphom
Memo magazine of european medical oncology
Proceedings of the annual meeting of the Austrian society of haematology and medical oncology. 2014; 7(1):14-15.-Frühjahrstagung ÖGHO; APR 10-12, 2014; Innsbruck.
[Poster]
Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M;
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
MODERN PATHOL. . 2013; 26(S2):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
LAB INVEST. . 2013; 93(S1):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
Belaj, K; Gary, T; Pichler, M; Eller, P; Hackl, G; Hafner, F; Gerger, A; Froehlich, H; Pilger, E; Brodmann, M
Lymphocyte-to-Monocyte Ratio: A Novel Marker for
Critical Limb Ischemia in PAOD Patients
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz.
[Poster]
Belaj, K; Pichler, M; Hackl, G; Eller, P; Brodmann, M; Gary, T
Derived Neutrophil-to-Lymphocyte Ratio and its
Association with Critical Limb Ischemia in PAOD
Patients
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz.
[Poster]
Belaj, K; Pichler, M; Hackl, G; Eller, P; Brodmann, M; Gary, T
Pathomechanism of reobstruction after endovascular treatment of the superficial femoral artery: impact of inflammatory cells
J THROMB HAEMOST. .. 2013; 11: 863-863.
[Poster]
Web of Science
Belaj,K; Hackl, G; Pichler,M; Eller,P; Brodmann,M; Gary,T
Derived Neutrophil-to-Lymphocyte Ratio and its association with critical limb ischemia in PAOD patients
VASA - Volume 42, Supplement 84 / 2013. 2013; -16. Dreiländertagung der Österreichischen, Schweizerischen und Deutschen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz.
[Oral Communication]
Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR
Analysis of plasma DNA using whole genome sequencing in patients with prostate cancer
Gordon Research Seminar & Conference; July, 7-12,2013; RI, USA. 2013.
[Oral Communication]
Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR
Whole genome plasma DNA sequencing as a non-invasive tool for personalized therapy in prostate cancer patients
EMBL Conference, Cancer Genomix; Nov 3-5, 2013; Heidelberg, Germany. 2013.
[Oral Communication]
Ehrlich, G; Pichler, M; Hutterer, G; Pummer, K; Zigeuner, R; Dalpiaz, O
Ein erhöhter Fibrinogen-Plasma-Spiegel ist ein negativer prognostischer Faktor beim Urothelkarzinom des oberen Harntraktes
Der Urologe Supplement 1. 2013; 52: 65-65.-65. Kongress der Deutschen Gesellschaft für Urologie; SEP 25-28, 2013; Dresden, GERMANY.
[Oral Communication]
Gary, T; Pichler, M; Belaj, K; Hafner, F; Brodmann, M;
Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-555.
[Poster]
Web of Science
Gary, T; Pichler, M; Belaj, K; Rief, P; Eller, P; Hafner, F; Gerger, A; Froehlich, H; Haas, E; Brodmann, M
Lymphocyte to Monocyte Ratio: A novel marker for critical limb ischemia in PAOD patients
Vasa. 2013; -Dreiländertagung Angiologie Graz; Sep 15-18, 2013; Graz.
[Oral Communication]
Hutterer, GC; Pichler, M; Stöckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R
Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of patients with renal cell carcinoma
Proceedings book of the 2013 Genitourinary Cancers Symposium;194. 2013; -2013 Genitourinary Cancers Symposium: A Transformative Multidisciplinary Approach; FEB 14-16, 2013; Orlando, FL.
[Poster]
Hutterer, GC; Pichler, M; Stöckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R
Hoher präoperativer Plasma-Fibrinogen-Spiegel als unabhängiger negativer Prognosefaktor bezüglich des krebsspezifischen, metastasenfreien und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center-Serie
Der Urologe Supplement 1. 2013; 52: 84-84.-65. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 25-28, 2013; Dresden, GERMANY.
[Poster]
Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R
A large scale validation study proposes high pre-operative plasma fibrinogen levels as an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of renal cell carcinoma patients
Eur Urol Suppl. 2013;12;e347.. 2013; -28th Annual EAU (European Association of Urology) Congress
; 15-19 Mar, 2013; Milan, IT.
[Poster]
Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R
A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301.
Doi: 10.1016/j.juro.2013.02.294
[Poster]
Web of Science
FullText
FullText_MUG
Jesche, J; Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R
Evaluierung der Wertigkeit der präoperativen Neutrophilen-/Lymphozyten-Ratio als Prognosefaktor bezüglich des krebsspezifischen-, metastasenfreien- und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House; 2013. DOI:10.3205/13oegu061. 2013; -39. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung, Graz; 06.-08.06.2013; Graz.
[Poster]
Jesche, J; Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R
Hoher präoperativer Plasma-Fibrinogen-Spiegel als unabhängiger negativer Prognosefaktor bezüglich des krebsspezifischen-, metastasenfreien- und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House; 2013. DOI:10.3205/13oegu058.
. 2013; -39. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung; 06.-08.06.2013; Graz.
[Poster]
Mohan, S; Heitzer,E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler,M; Eisner,F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR;
Development of acquired resistance to anti-EGFR therapy in colorectal cancer identified by whole-genome plasma DNA sequencing
Doctoral Day; Dec 9, 2013; Graz. 2013.
[Poster]
Ress, AL; Aigelsreiter, A; Schauer, S; Eisner, F; Samonigg, H; Lackner, C; Haybaeck, J; Bauernhofer, T; Pichler, M
Correlation of loss of spinophilin expression with increased proliferation and viability as a prognostic factor in patients with hepatocellular carcinoma.
2013 ASCO Annual Meeting; Mai 31- Juni 4, 2013; Chicago. 2013.
Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Zacherl, M; Renner, W; Leithner, A; Gerger, A
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P4:102. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Poster]
Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg, H; Stojakovic, T; Gerger, A; Leithner, A
Elevated preoperative neutrophil/lymphocyte ratio is associated
with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; PSR:110. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Oral Communication]
Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg; H; Stojakovic, T; Gerger, A; Leithner, A
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P6:101. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Poster]
Szkandera, J; Absenger, G; Weissmueller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2
Journal of Clinical Oncology . 2013; 30(34):-2013 Gastrointestinal Cancers Symposium; Jan 24-26, 2013; San Francisco, USA.
[Poster]
Szkandera, J; Absenger, G; Weissmueller, M; Stotz, M; Pichler, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A
A common gene variant in AXIN2 predicts clinical outcome in stage II and III colon cancer
387 (A55). 2013; -ASCO GI; JAN 24-26, 2013; San Francisco, USA.
[Poster]
Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Leithner, A; Gerger, A
THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR CANCER-SPECIFIC; METASTASIS-FREE AND OVERALL SURVIVAL IN SOFT-TISSUE SARCOMA PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 93. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA.
[Poster]
Wallner, M; Rainer, PP; Mächler, H; Pichler, M; Pieske, B; von Lewinski, D
Funktionelle Effekte der Multikinase-Inhibitoren Sorafenib und Sunitinib
Supplement 01/13 Wiener Klinische Wochenschrift; XIV-5. 2013; -Österreichische Kardiologische Gesellschaft Jahrestagung 2013; JUN 5-8; 2103; Salzburg, AUSTRIA.
[Poster]
Wallner, M; Rainer, PP; Mächler, H; Pichler, M; Pieske, B; von Lewinski, D;
Kardiotoxische Effekte von Multikinase Inhibitoren
Clin Res Cardiol 102, Suppl 1, April 2013; P1705 . 2013; -79. Jahrestagung der Deutschen Gesellschaft für Kardiologie; APR 3-6, 2013; Mannheim, GERMANY.
[Poster]
Winder, T; Szkandera, J; Absenger, G; Weismüller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Samonigg, H; Gerger, A
A functional germline variant in Hedgheog pathway gene GLI1 identifies patients at high risk of tumor recurrence in stage II and III colon cancer
http://worldgicancer.com/WCGI/WGIC2013/. 2013; -World Congress on Gastrointestinal Cancer; July 3-6, 2013; Barcelona, Spain.
[Oral Communication]
Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A;
The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER;
[Poster]
Web of Science
Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Hayback, J; Denk, H; Lackner, C
Prognostic relevance of Mallory-Denk and intracytoplasmic hyaline bodies in hepatocellular carcinoma
HEPATOLOGY. 2012; 56: 474A-475A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Haybaeck, J; Denk, H; Lackner, C
PROGNOSTIC RELEVANCE OF MALLORY-DENK BODIES AND INTRACELLULAR HYALINE BODIES IN HEPATOCELLULAR CARCINOMA
J HEPATOL. 2012; 56: S287-S287.
Doi: 10.1016/S0168-8278(12)60741-7
[Oral Communication]
Web of Science
FullText
FullText_MUG
Belic, J; Auer, M; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Ulz, P; Geigl, J; Augustin, H; Eisner, F; Höfler, G; Pantel, K; Riethdorf, S; Geigl, JB; Speicher, MR
Characterization of circulating tumor cells and plasma DNA in patients with prostate cancer
Doctoral day; dec 7,2012; Graz, Austria. 2012.
[Poster]
Deutsch, A; Pichler, M; Reitter, S; Troppan, K; Beham-SChmid, C; Neumeister, P.
Reduced NR4A1 expression is associated with poor survival in patients with aggressive lymphomas.
2012 Proceedings of the annual meeting of the Austrian Society of Haematology and Oncology. 2012; 5(1):5-5.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria.
[Poster]
Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P;
Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
[Oral Communication]
Web of Science
Deutsch, AJA; Rinner, B; Pichler, M; Reitter, S; Beham-Schmid, C; Neumeister, P;
NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
Doi: 10.1182/blood.V120.21.2408.2408
[Poster]
Web of Science
FullText
FullText_MUG
Eisner, F; Pichler, M; Gerger, A; Schaberl-Moser, R; Samonigg, H
49 Monate Progressions-freies Überleben bei einem Patienten mit metastasiertem Kolonkarzinom unter Avastin- Erhaltungstherapie Ein Fallbericht
Frühjahrstagung der Österreichischen Gesellschaft für Hämtologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Eisner, F; Schaberl-Moser, R; Pichler, M; Samonigg, H
The multi-kinase inhibitor sorafenib in metastatic follicular thyroid cancer a case report
Frühjahrstagung der Österreichischen Gesellschaft für Hämatlogie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Eisner, F; Stotz, M; Samonigg, H; Lax, S; Hoefler, G; Pichler, M
Down-regulation of KRAS-interacting miRNA-143 to predict prognosis and response to EGFR-targeted agents in colorectal cancer.
ASCO Annual Meeting 2012; JUN 1-5, 2012; Chicago, USA. 2012.
FullText
Gary, T; Belaj, K; Eisner, F; Pichler, M; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-559.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; ; Graz, AUSTRIA. . .
[Poster]
Web of Science
Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY.
Doi: 10.1016/S0049-3848(12)70103-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Gary, T; Belaj, K; Steidl, K; Pichler,M; Eisner, F; Stoeger,H; Hafner, F; Froehlich,H; Samonigg, H; Pilger,E; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012.
[Oral Communication]
Hutterer, GC; Pichler, M; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Comparison of the 2002 and 2010 TNM classification system regarding the prediction of metastasis-free survival in patients with renal cell carcinoma.
J Urol Suppl 2012;187(4S):E286
. 2012; -107th American Urological Association (AUA) Annual Meeting; MAY 19-23; Atlanta, GA, USA.
[Poster]
Hutterer, GC; Pichler, M; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Comparison of the 2002 and 2010 version of the TNM classification system regarding the prediction of metastasis-free survival in patients with renal cell carcinoma.
Proceedings book of the 2012 Genitourinary Cancers Symposium;179.. 2012; -2012 Genitourinary Cancers Symposium: Novel Mechanisms and Therapies in Multidisciplinary Management; FEB 2-4, 2012; San Francisco, CA.
[Poster]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
Blood-based treatment monitoring of metastatic colorectal
cancer patients by KRAS mutation analysis
Frühjahrstagung der österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2012; Graz. 2012.
[Poster]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
KRAS mutation analysis using blood derived cell free tumor DNA for treatment monitoring of metastatic colorectal cancer patients
Cancer Res., . 2012; 72: 4513. : -AACR Annual Meeting; MAR 31- APR 4, 2012; Chicago, USA.
[Poster]
Pichler, M;
MicroRNAs als Theragnostika beim Kolorektal-Karzinom
Frühjahrstagung der Österreichischen Gesellschaft für Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Oral Communication]
Pichler, M; Doleschal, B; Groschner, K; Maechler, H; Bauernhofer, T; Kass, D; Pieske, B; von Lewinski, D; Samonigg, H; Rainer, P
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
Frühjahrstagung der Österreichischen Gesellschaft für Hämatolologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Validation of the 2002 and 2010 TNM classification systems for the prediction of metastasis-free and overall survival in renal cell carcinoma patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Renal cell carcinoma stage migration in a single European center over 25 years: effects on 5 and 10 years metastasis-free survival
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Prognostic Value of the Leibovich Prognosis Score Supplemented by Vascular Invasion for Clear Cell Renal Cell Carcinoma.
Workshop des FF-Krebsforschung; APR 23, 2012; Graz, Austria.
[Oral Communication]
Pichler, M; Winter, E; Bauernhofer, T; Lax, S; Samonigg, H; Hoefler, G
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Tinchon, C; Hubmann, E; Pichler, M; Rabl, H; Uggowitzer, M; Jilek, K; Leitner,G; Bauernhofer,T;
Neoadjuvant FOLFIRINOX in pancreatic cancer:
a series of 11 patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz. 2012.
[Poster]
Doleschal, B; Rainer, PP; Saad, Z; Groschner, K; Mächler, H; Höfler, G; Samonigg, H; Pieske, B; von Lewinski, D; Pichler; M
Der Multikinaseinhibitor Sunitinib hat akute Auswirkungen auf die kardiale Kontraktilität
J f Kardiologie. 2011; -Annual Session of the Austrian Society for Cardiology; MAY 25-28, 2011; Salzburg.
[Poster]
Doleschal, B; Rainer, PP; Saad, Z; Groschner, Maechler, H; K; Hoefler, G; Samonigg; Pieske, BM; von Lewinski, D; Pichler, M;
Acute effects of the targeted anti-cancer agent sunitinib on cardiac contractility
European Heart Journal. 2011; 32(1):294--ESC Congress; Aug 27-31, 2011; Paris, Austria.
[Poster]
Eichmann, E; Eisner, F; Stojakovic, T; Kiesslich, T; Lackner, C; Bauernhofer, T; Mischinger, H; Samonigg, H; Pichler, M
Prognostic value of commonly measured laboratory parameters in
patients with biliary malignancies.
EUROPEAN SURGERY Acta Chirurgica Austriaca . 2011; -52. Österreichischer Chirurgenkongress; JUN 23-25, 2011; Vienna, AUSTRIA.
[Poster]
Kiesslich, T; Neureiter, D; Alinger, B; Wolkersdörfer, GW; Pichler, M; Ocker, M; Plätzer, K; Berr, F
Cellular Phenotype and Photosensitiser Uptake as Determinants
of the Efficiency of Photodynamic Therapy (PDT) for Biliary Tract Cancer
. 2011; -13th IPA World Congress; MAY 10-14, 2011; Innsbruck, AUSTRIA.
[Poster]
Kiesslich T, Wachter J, Alinger B, Pichler M, Ocker M,
Neureiter D, Berr F.
HEDGEHOG-SIGNALLING ALS MOLEKULARES TARGET
BEIM GALLENWEGSKARZINOM?
44. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 16-18, 2011; Salzburg. 2011.
[Poster]
Aigelsreiter, A; Osprian, I; Sauseng, S; Lackner, C; Samonigg, H; Mischinger, HJ; Pichler, M
Trends in overall and disease-free survival after curative hepatic resection for hepatocellular carcinoma
51. Chirurgenkongress; JUN 2-4, 2010; Linz, AUSTRIA. 2010.
[Poster]
Aigelsreiter, A; Osprian, I; Sauseng, S; Lackner, C; Samonigg, H; Mischinger, HJ; Pichler, M
Liver resection for hepatocellular carcinoma in cirrhotics and non-cirrhotics: evaluation and comparison of long-term and recurrence-free survival
51. Chirurgenkongress; JUN 2-4, 2010; Linz, AUSTRIA. 2010.
[Poster]
Auprich, M; Budäus, L; Luger, F; Pichler, M; Gallé, G; Mannweiler, S; Chun, FK; Pürstner, P; Pummer, K; Augustin, H
PSA velocity and PCA3 score as risk factors for prostate cancer in a repeat biopsy setting improves the predictive accuracy in a multivariate model.
European Urology Supplements2010; 9(2):307--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
Auprich, M; Budäus, L; Luger, F; Pichler, M; Gallé, G; Mannweiler, S; Chun, FK; Pürstner, P; Pummer, K; Augustin, H
PSA-Velocity und PCA3-Score verbessern die Vorhersagegenauigkeit für das Prostatakarzinom bei Wiederholungsbiopsien.
Journal für Urologie und Urogynäkologie. 2010; 17(3):11--36. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie; JUN 10-12; München, GERMANY.
[Oral Communication]
Auprich, M; Gutschi, St; Gallé, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H
Transurethrale Prostataresektion und PCA3-Score: Zusammenhänge und Ergebnisse einer 6-monatigen prospektiven Studie
Journal für Urologie und Urogynäkologie. 2010; 17(3):34--36. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie; JUN 10-12; München, GERMANY.
[Oral Communication]
Auprich, M; Gutschi, St; Gallé, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H
Systematischer Vergleich eines 24-fach Saturationsschemas mit Transitionalzonenbiopsien gegen 62 verschiedene reduzierte Prostatabiopsieschemen nach mindestens einer negativen Biopsie.
Journal für Urologie und Urogynäkologie. 2010; 17(3):41--36. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie; JUN 10-12; München, GERMANY.
[Oral Communication]
Auprich, M; Gutschi, St; Gallé, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H
Systematic analysis of saturation biopsy with 20 peripheral cores and 4 cores from the transition zone based on 62 reduced biopsy schemes after at least one negative biopsy.
The Journal of Urology. 2010; 183(4):361--American Urological Association Annual Meeting; MAY 29- JUN 3; San Francisco, USA.
[Oral Communication]
Auprich, M; Gutschi St; Galle, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H
Systematic analysis of saturation biopsy with 20 peripheral cores and 4 cores from the transition zone based on 62 reduced biopsy schemes after at least one negative biopsy
EUR UROL SUPPL. 2010; 9(6):654-654.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
Doi: 10.1016/S1569-9056(10)61668-5
[Poster]
Web of Science
FullText
FullText_MUG
Beckendorf, J; Hoefler, G; Winter, E; Kleinert, R; Kniepeiss, D; Pichler, M
Quantitative Analyse der Empfängerzell-DN A als Methode zur Beurteilung
von akuten Abstoßungsreaktionen in transplantierten Herzen
Austrotransplant 2010; OCT 27-29, 2010; Viellach, Austria. 2010.
[Oral Communication]
Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
Elevated plasma fibrinogen level represents an independent prognostic factor in breast cancer patients.
Radiotherapy and Oncology - Journal of the European Society for Radiotherapy and Oncology. 2010; 111: -European Society for Radiotherapy and Oncology 33; APR 4-8, 2014; Vienna, AUSTRIA.
[Poster]
Mohamad Al-Ali, B; Pichler, M; Gstettner, C; Galle, G; Jesche, J; Pummer, K
Haben an einem unilateralen Hodenkarzinom (TC) erkrankte Männer ein erhöhtes Risiko bilateral ein Hodenkarzinom oder ein Carcinoma in situ
des Hodens (TIN) zu entwickeln?
43.Alpenländisches Urologensymposium; 17-20 März 2010; Bad Hofgastein. 2010.
[Oral Communication]
FullText
Mohamad Al-Ali, B; Pichler, M; Gstettner, C; Galle, G; Pummer, K
Haben an einem unilateralen Hodenkarzinom erkrankte Männer ein erhöhtes Risiko, bilateral ein Hodenkarzinom zu entwicklen
Journal für Urologie und Urogynäkologie2010; Sonderheft 3 : 35-35.-36.Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; 10-12 Juni 2010; München.
[Oral Communication]
Rühlinger, D; Szkandera, J; Pichler, M; Eisner, F; Stöger, H; Bauernhofer, T;
Sorafinib as forth-line treatment in a patient with metastatic gastrointestinal stromal tumour: a case report.
MEMO Suppl 01/10; 2010; 20-20.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA.
[Poster]
Aigelsreiter, A; Stiegler, P; Pichler, M; Stoger, H; Roob, J; Horn, S; Ratschek, M; Hofler, G; Lackner, C
Transmission of metastasizing high-grade hepatocellular carcinoma from a donor with liver cirrhosis
VIRCHOWS ARCHIV. 2009; 455: 442-442.-22nd Congress of Pathology, European Society of Pathology; SEP 4 - 9, 2009; Florenz, ITALY.
[Poster]
Web of Science
Pichler, M; Balic M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors
joint ZMF & Doctorial Day ; NOV 4-5, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Gülly C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N;
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumours.
Frühjahrstagung 2009 der Österreichischen Gessellschaft für Hmatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg. 2009.
[Oral Communication]
Pichler, M; Samonigg, H; Bauernhofer, T;
Rhabdomyolysis as a complication of trabectedin (Yondelis) treatment in metastatic leiomyosarcoma: a case report.
Frühjahrstagung 2009 der Österreichischen gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg, AUSTRIA. 2009.
[Poster]
Kaniewska, M; Schweiger, S; Huber, M; Pichler, M; Abuja, P; Schmid, M
SIMULTANEOUS DETERMINATION OF S-ADENOSYL-METHIONINE AND S-ADENOSYLHOMOCYSTEINE
IN TISSUE BY CAPILLARY ELECTROPHORESIS
http://aok.pte.hu/bioanalitika/meetings/InstrAnal2008/Program-2008.pdf2008; -9th INTERNATIONAL SYMPOSIUM ON INSTRUMENTAL ANALYSIS; JUN-JUL 29-2, 2008; Pecs, Hungary.
[Poster]
Aigelsreiter, A; Halasz, J; Lackner, C; Sostaric, J; Reihs, R; Stark, K; Kufferath, I; Pichler, M; Stumptner, C; Zatloukal, K; Denk, H
Hepatocellular carcinomas with Mallory bodies and/or Intracellular hyaline bodies: Correlation with steatohepatitic features
Virchows Archive
. 2007; 451(2):370-370.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, TURKEY.
[Poster]
Web of Science
Aigelsreiter, A; Janig, E; Halasz,, J; Lackner, C; Sostaric, J; Pichler, M; Stumptner,, C; Unterthor, D; Kufferath,, I; Zatloukal, K; Denk, H
Clusterin expression in cholestasis and liver fibrosis
Virchows Archive. 2007; 451(2):132-132.-21th European Congress of Pathology; SEPT 8-13; Istanbul, TURKEY.
[Oral Communication]
Web of Science
Pichler, M; Abuja, P; Aigelsreiter, A; Mischinger, HJ; Denk, H; Zatloukal, K
Overexpression of glutathione synthesizing enzymes in a mouse model fur drug-induced steatohepatitis
Virchows Archive
. 2007; 451(2):567-567.-21th European Congress of Pathology ; SEPT 8-13, 2007; Istanbul, TURKEY.
[Poster]
Web of Science
Pichler, M; Dandachi, N; Kleinert, R; Tscheliessnigg, KH; Hoefler, G
STR-analysis in diagnosing acute cellular rejection in cardiac transplantation
Clinical Chemistry and Laboratory Medicine2007; -Gemeinsamer Kongress der
Österreichischen Gesellschaft
für Laboratoriumsmedizin und Klinische Chemie (ÖGLMKC) und der
Deutschen Vereinten Gesellschaft
für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 19-22, 2007; Vienna, Austria.
[Poster]
Pichler, M; Hatz, M; Aigelsreiter, A; Mischinger HJ; Denk, H; Zatloukal, K
Altered S-Adenosylmethionine metabolism in a Mallory body mouse model
Virchows Archive . 2007; 451(2):377-378.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, Turkey.
[Poster]
Web of Science
Pichler, M; Hoefler, G; Maderbacher, M; Gülly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of High Resolution Melting Analysis, Denaturing High Pressure Liquid Chromatography and DNA Sequencing for detection of Mutations in human colorectal tumor samples
2nd Gene Expression Symposiom; Oct 2007; Graz, Austria. 2007.
[Poster]
Pichler, M; Mischinger, HJ; Ratschek, M; Hatz, M; Hrzenjak, A; Zatloukal, K
A real-time qPCR-based assay for assessment of mRNA quality derived from paraffin-embedded tissues
PATHOL RES PRACT. 2007; 203(5):396-396.-91. Jahrestagung der Deutschen Gesellschaft für Pathologie.; MAY 30 - JUN 2, 2007; Magedeburg, GERMANY.
[Poster]
Web of Science
Pichler M, Schmidt R, Mark T, Becsagh P, Fazekas F, Schmidt H
C-reactive protein 3´UTR +1444C>T polymorphism in patients with carotid atherosclerosis
Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Alzheimer, Neurologie und Psychiatrie; APR 25-28, 2007; Salzburg. 2007.
[Oral Communication]
Pichler, M; Tockner, S; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of real-time PCR instruments for the detection of melanoma cell markers
Clinical Chemistry and Laboratory Medicine2007; -Gemeinsamer Kongress der
Österreichischen Gesellschaft
für Laboratoriumsmedizin und Klinische Chemie (ÖGLMKC) und der
Deutschen Vereinten Gesellschaft
für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 19-22, 2007; Vienna, Austria.
[Poster]
Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H
Baseline C-reactive protein serum level and the influence of CRP gene polymorphisms
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. CLINICAL CHEMISTRY AND LABORATORY MEDICINE.2006; VOL.44(NO.9):205-206.-1st Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OKT 4-7, 2006; Salzburg, AUSTRIA.
[Poster]
Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H
The +1444C>T polymorphism in the 3´untranslated region of CRP gene influences baseline C-reactive protein serum level
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL.44(NO.9):205-206.-1st Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OKT 4-7, 2006; Salzburg, AUSTRIA.
[Poster]
Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H
The +1444C>T polymorphism in the 3´untranslated region of CRP gene influences baseline C-reactive protein serum level
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL.44(NO.9):139-140.-Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin; OKT 1-4, 2006; Mannheim, GERMANY.
[Oral Communication]
Pichler, M; Tessaro, B; Kleinert, R; Tscheliessnigg, K; Höfler, G
Intragraft chimerism and cellular rejection in human transplanted heart
European Surgery (ACA). 2006; 38(211): 16-17..
[Oral Communication]